Key facts
- Notable investors include Jumpspeed.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zoharay
- ·The full record, as it builds
Funding rounds
No funding rounds for Zoharay are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zoharay
Provider of advanced neuro-visual and medical-grade biological products designed for healthcare researchers to improve diagnostic accuracy. The company unites scientific research in neurobiology and botany with modern diagnostic technology that provides high-precision visual assessment tools and biological research models, enabling clinicians to transition from observational data to an evidence-based ecosystem.
- Sector
- Healthcare
- HQ
- Jerusalem, Israel
- Founded
- 2023
- Website
- zoharay.com/
- Ownership
- Privately Held (backing)
Zoharay doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zoharay shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zoharay in its N-PORT filings yet. We sweep new filings monthly.